Astroglia growth retardation and increased microglia proliferation by lithium and ornithine decarboxylase inhibitor in rat cerebellar cultures: Cytotoxicity by combined lithium and polyamine inhibition

Journal of Neuroscience Research

Volumn 85, Issue 3, 2007, Pages 594-601

  Gilad, Gad M ^a   Gilad, Varda H ^a  

^a G and V Gilad Ltd   (Israel)

Author keywords

difluoromethylornithine; Astrocytes; Neuroprotection

Indexed keywords

EFLORNITHINE; LITHIUM; ORNITHINE DECARBOXYLASE INHIBITOR; POLYAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CEREBELLUM CORTEX; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; GROWTH RETARDATION; MACROGLIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL SURVIVAL; CEREBELLUM; EDETIC ACID; EFLORNITHINE; ENZYME INHIBITORS; LITHIUM CHLORIDE; MICROGLIA; ORNITHINE DECARBOXYLASE; RATS;

EID: 33847322998     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21152     Document Type: Article

References (61)

1. Aldskogius H, Kozlova EN. 1998. Central neron-glial and glial-glial interactions following axon injury. Prog Neurobiol 55:1-26.
2. Avissar S, Schreiber G, Danon A, Belmaker RH. 1988. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331:440-442.
3. Berridge MJ. 1987. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem 56:159-193.
4. Berridge MJ, Downes CP, Hanley MR. 1989. Neural and developmental action of lithium: a unifying hypothesis. Cell 59:411-419.
5. Bueb J-L, Da Silva A, Mousli M, Landry Y. 1992. Natural polyamines stimulate G-proteins. Biochem J 282:545-550.
6. i in cultured astrocytes by chronic treatment with therapeutically relevant lithium concentration. Brain Res 711:245-248.
7. Coyle JT, Duman RS. 2003. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157-160.
8. + protection of cerebellar granule neurons switched to nondepolarizing medium. Eur J Pharmacol 315:111-114.
9. D'Mello SR, Galli C, Ciotti T, Calissano P. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci U S A 90:10989-10993.
10. D'Mello SR, Galli C, Ciotti T, Calissano P. 1994. Lithium inducec apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res 211:332-338.
11. Ebstein RP, Hermoni M, Belmaker RH. 1980. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: Inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther 213:161-166.
12. Flamigni FF, Stefanelli C, Caldarera CM. 1986. Polyamine metabolism and function in the heart. J Mol Cell Cardiol 18:3-11.
13. Gilad GM, Gilad VH. 1981. Cytochemical localization of ornithine decarboxylase with rhodamine- or biotin-labeled a-difluoromethylornithine: an example for the use of labeled irreversible enzyme inhibitors for cytochemical markers. J Histochem Cytochem 29:687-692.
14. Gilad GM, Gilad VH. 1986. Polyamines affect growth of cultured rat cerebellar neurons in different sera. Int J Dev Neurosci 4:195-208.
15. Gilad GM, Gilad VH. 1987. Detachment of cultured neurons from substratum by astrocytic membrane-associated activity: implications for CNS regeneration? Int J Dev Neurosci 5:79-89.
16. Gilad GM, Gilad VH. 1992. Polyamines in neurotrauma; ubiquitous molecules in search of a function. Biochem Pharmacol 44:401-407.
17. Gilad GM, Gilad VH. 1995. Chemotaxis and accumulation of nerve growth factor by microglia and macrophages. J Neurosci Res 41:594-602.
18. Gilad GM, Gilad VH. 1996. The brain polyamine stress response: recurrence after repetitive stressor and inhibition by lithium. J Neurochem 67:1992-1996.
19. Gilad GM, Gilad VH. 2003. The polyamine stress response. Regulation, development, modulation by lithium and role in cell survival. Cell Mol Neurobiol 23:637-649.
20. Gilad GM, Gilad VH, Dahl D, Bignami A. 1988. Astroglia-induced detachment of central neurons but astroglia-dependent growth of peripheral neurons in rat embryonic spinal cord primary cultures. Brain Res 458:249-260.
21. Gilad GM, Dahl D, Gilad VH. 1989. Effects of glycosaminoglycans and proteinase inhibitors on astroglia-induced detachment of cultured rat cerebellar neurons. Int J Dev Neurosci 7:133-143.
22. Gilad GM, Shanker G, Dahl D, Gilad VH. 1990. Dibutyryl cyclic AMP-induced changes in neuron-glia interactions and fibronectin immunocytochemistry in dissociated rat cerebellar cultures. Brain Res 508:215-224.
23. Gilad GM, Gilad VH, Wyatt RJ, Casero RA Jr. 1992. Chronic lithium treatment prevents the dexamethasone-induced increase of brain polyamine metabolizing enzymes. Life Sci 50:PL149-PL154.
24. Gilad GM, Gilad VH, Eliyayev Y, Rabey JM. 1998. Developmental regulation of the brain polyamine stress response. Int J Dev Neurosci 16:271-278.
25. Gilad GM, Balakrishnan K, Gilad VH. 1999. The course of putrescine immunocytochemical appearance in neurons, astroglia and microglia in rat brain cultures. Neurosci Lett 268:33-36.
26. Jope RS, Williams MB. 1994. Lithium and brain signal transduction systems. Biochem Pharmacol 47:429-441.
27. Kanba S, Yagi G, Nakaki T, Kato R, Richelson E. 1991. Potentiation by a sodium channel activator of effects of lithium ion on cyclic AMP, cyclic GMP and inositol phosphates. Neuropharmacology 30:497-500.
28. Lachman HM, Papolos DF. 1989. Abnormal signal transduction: a hypothetical model for bipolar affective disorder. Life Sci 45:1413-1426.
29. Levine S, Saltzman A, Klein AW. 2000. Proliferation of glial cells in vivo induced in the neural lobe of the rat pituitary by lithium. Cell Prolif 33:203-207.
30. Li PP, Sibony D, Green MA, Warsh JJ. 1993. Lithium modulation of phosphoinositide signaling system in rat cortex - selective effect on phorbol ester binding. J Neurochem 61:1722-1730.
31. Lubrich B, van Calker D. 1999. Inhibition of high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs? Neuropsychopharmacology 21:519-529.
32. Lubrich B, Spleiss O, Gebicke-Haerter PJ, van Calker D. 2000. Differential expression, activity and regulation of the sodium/myo-inositol cotransporter in astrocyte cultures from different regions of the rat brain. Neuropharmacology 39:680-690.
33. Manji HK, Etcheberrigaray R, Chen G, Olds JL. 1993. Lithium decreases membrane-associated protein kinase-C in hippocampus - selectivity for the alpha-isozyme. J Neurochem 61:2303-2310.
34. Manji HK, Moore Gj, Rajkowska G, Chen G. 2000. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5:578-593.
35. Masana MI, Bitran JA, Hsiao JK, Potter WZ. 1992. In vivo evidence that lithium inactivates GI modulation of adenylate cyclase in brain. J Neurochem 59:200-205.
36. Matsui I, Pegg AE. 1980. Effect of thioacetamide, growth hormone or partial hepatectomy on spermidine acetylase activity of rat liver cytosol. Biochim Biophys Acta 633:87-94.
37. Moonen G, Cam Y, Sensenbrenner M, Mandel P. 1975. Variability of the effects of serum-free medium, dibutyryl-cyclic AMP or theophylline on the morphology of cultured newborn rat astroblasts. Cell Tissue Res 163:365-372.
38. Moruzzi MS, Marverti G, Piccinini G, Frassineti C, Monti G. 1993. Effect of spermine on membrane associated and membrane-inserted forms of protein kinase C. Mol Cell Biochem 124:1-9.
39. Nichols CG, Makhina EN, Pearson WL, Sha O, Lopatin AN. 1996. Inward rectification and implications for cardiac excitability. Circ Res 78:1-7.
40. Nonaka S, Hough CJ, Chuang DM. 1998. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A 95:2642-2647.
41. Pardo R, Andreolotti AG, Ramos B, Picatoste F, Claro E. 2003. Opposed effects of lithium on the MEK-ERK pathway in neural cells; inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms. J Neurochem 87:417-426.
42. Periyasami S, Kothapalli MR, Hoss W. 1994. Regulation of the phosphoinositide cascade by polyamines in brain. J Neurochem 63:1319-1327.
43. Queiroz G, Meyer DK, Meyer A, Starke K, von Kugelgen I. 1999. A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 91:1171-1181.
44. Richards SF, Fox K, Peng T, Hsiao J, Gout PW. 1990. Inhibition of hormone-stimulated ornithine decarboxylase activity by lithium chloride. Life Sci 47:233-240.
45. Rowe MK, Chuang DM. 2004. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med 6:1-18.
46. Schuber F. 1989. Influence of polyamines on membrane functions. Biochem J 260:1-10.
47. Schubert T, Stoll L, Muller WE. 1991. Therapeutic concentrations of lithium and carbamazepine inhibit cGMP accumulation in human lymphocytes. A clinical model for a possible common mechanism of action? Psychopharmacology 104:45-50.
48. Seiler N. 1991. Pharmacological properties of natural polyamines and their depletion by biosynthesis inhibitors as a therapeutic approach. Prog Drug Res 37:107-159.
49. Seiler N, Bolkenius FN. 1985. Polyamine reutilization and turnover in brain. Neurochem Res 10:529-544.
50. Seiler N, Sarhan S, Roth-Schechter BF. 1984. Polyamines and the development of isolated neurons in cell culture. Neurochem Res 9:871-885.
51. Shao L, Sun X, Xu L, Young LT, Wang JF. 2005. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci 78:1317-1323.
52. Singh SS, Chauhan A, Brockerhoff H, Chauhan VPS. 1995. Differential effects of spermine on phosphatidylinositol 3-kinase and phosphatidylinositol 5-kinase. Life Sci 57:685-694.
53. Song L, Zhou T, Jope RS. 2004. Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci 5:20.
54. Sparapani M, Virgili M, Bardi G, Tregnago M, Monti B, Bentivogli M, Contestabile A. 1998. Ornithine decarboxylase activity during developmental survival or apoptotic death of cerebellar granule neurons. J Neurochem 71:1898-1904.
55. Tabor CW, Tabor H. 1984. Polyamines. Annu Rev Biochem 53:749-790.
56. Walz W, Hertz E, Hertz L. 1983. Lithium-potassium interaction in acutely treated cortical neurons and astrocytes. Prog Neuropsychopharmacol Biol Psychiatry 7:697-702.
57. Wolfson M, Hertz E, Belmaker RH, Hertz L. 1998. Chronic treatment with lithium and pretreatment with excess inositol reduce inositol pool size in astrocytes by different mechanisms. Brain Res 787:34-40.
58. Xu J, Culman J, Blume A, Brecht S, Gohlke P. 2003. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 34:1287-1292.
59. s α-subunit levels are elevated in bipolar affective disorder. Brain Res 553:323-326.
60. Zamfirescu G, Buzgariu W, Uluitu M, Tesio C. 2000. Alterations induced by lithium in GFAP expression and in the proteinic composition of glial cells in vitro. Rom J Physiol 37:81-89.
61. Zhou R, Gray NA, Yuan P, Li X, Chen J, Chen G, Damschroder-Williams P, Du J, Zhang L, Manji HK. 2005. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the action of mood stabilizers. J Neurosci 25:4493-4502.